Effect of anticholinergic burden on the development of dementia in older adults with subjective cognitive decline

References

• Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population- based studies. Int J Geriatr Psychiatry. 2000;15(11):983–991. doi: 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Jorm AF, Christensen H, Korten AE, et al. Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7–8 years. Psychol Med. 2001;31(3):441–449.
   PubMed Web of Science ®Google Scholar
• Pearman A, Storandt M. Self-discipline and self-consciousness predict subjective memory in older adults. J Gerontol B Psychol Sci Soc. 2005;60(3):153–157. doi: 10.1093/geronb/60.3.P153
   PubMed Web of Science ®Google Scholar
• Waldorff FB, Siersma V, Vogel A, et al. Subjective memory complaints in general practice predicts future dementia: a 4-year follow-up study. Int J Geriatr Psychiatry. 2012;27(11):1180–1188. doi: 10.1002/gps.3765
   PubMed Web of Science ®Google Scholar
• Abner EL, Kryscio RJ, Caban-Holt AM, et al. Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial. J Prev Alzheimers Dis. 2015;2(1):11–16.
   PubMedGoogle Scholar
• Zwan MD, Villemagne VL, Dore V, et al. Subjective memory complaints in APOƐE4 carriers are associated with high amyloid-β burden. J Alzheimers Dis. 2015;49(4):1115–1122. doi: 10.3233/JAD-150446
   Web of Science ®Google Scholar
• Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56(7):1333–1341. doi: 10.1111/j.1532-5415.2008.01737.x
   PubMed Web of Science ®Google Scholar
• Gray SL, Joseph T. Hanlon. anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf. 2016;7(5):217–224. doi: 10.1177/2042098616658399
   PubMedGoogle Scholar
• Kersten H, Wyller TB. Anticholinergic drug burden in older people’s brain – how well is it measured? Basic Clin Pharmacol Toxicol. 2014;114(2):151–159. doi: 10.1111/bcpt.12140
   PubMed Web of Science ®Google Scholar
• Fox C, Smith T, Maidment I, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age and Ageing. 2014;43(5):604–6615. doi: 10.1093/ageing/afu096
   PubMed Web of Science ®Google Scholar
• Naples JG, Zachary AM, Perera S, et al. Concordance among anticholinergic burden scales. J Am Geriatr Soc. 2015;63(10):2120–2124. doi: 10.1111/jgs.13647
   PubMed Web of Science ®Google Scholar
• Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30(2):103–112. doi: 10.1007/s40266-012-0044-x
   PubMed Web of Science ®Google Scholar
• Campbell NL, Boustani MA, Lane KA, et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology. 2010;75(2):152–159. doi: 10.1212/WNL.0b013e3181e7f2ab
   PubMed Web of Science ®Google Scholar
• Shah RC, Janos AL, Kline JE, et al. Cognitive decline in older persons initiating anticholinergic medications. PLoS One. 2013;8(5): e64111. doi: 10.1371/journal.pone.0064111
   Web of Science ®Google Scholar
• Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59(8):1477–1483. doi: 10.1111/j.1532-5415.2011.03491.x
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein S, McHugh PR. “Minimental state”: a practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Cangoz B, Karakoc E, Selekler K. The norm determination and validity-reliability studies of clock drawing test on Turkish adults and elderly (ages 50 and over). Turk J Geriatr. 2006;9(3):136–142.
   Google Scholar
• Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clinical Gerontologist. 1986;5:165–172. doi: 10.1300/J018v05n01_09
   Google Scholar
• Reisberg B, Prichep L, Mosconi L, et al. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease. Alzheimers Dement. 2008;4(1):S98–S108. doi: 10.1016/j.jalz.2007.11.017
   PubMed Web of Science ®Google Scholar
• Reid LM, Maclullich AM. Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord. 2006;22(5-6):471–485. doi: 10.1159/000096295
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistic manual of mental disorders. 4th ed. Printing Washington (DC): American Psychiatric Association; 1994.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Printing Arlington (VA): American Psychiatric Publishing; 2013.
   Google Scholar
• Campbell NL, Maidment I, Fox C, et al. The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc. 2013;61(1):142–143.
   Google Scholar
• Zia A, Kamaruzzaman S, Myint PK, et al. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas. 2016;84:32–37. doi: 10.1016/j.maturitas.2015.10.009
   PubMed Web of Science ®Google Scholar
• Konishi K, Hori K, Hachisu M, et al. Assessment of cognitive dysfunction caused by anticholinergic burden in Japanese Alzheimer’s disease patients, using the most commonly used scales in Japan. Nihon Shinkei Seishin Yakurigaku Zasshi. 2015;35(5-6):113–118.
   Google Scholar
• Jessen F, Feyen L, Freymann K, et al. Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol Aging. 2006;27(12):1751–1756. doi: 10.1016/j.neurobiolaging.2005.10.010
   PubMed Web of Science ®Google Scholar
• Wang L, van Belle G, Crane PK, et al. Subjective memory deterioration and future dementia in people aged 65 and older. J Am Geriatr Soc. 2004;52(12):2045–2051. doi: 10.1111/j.1532-5415.2004.52568.x
   PubMed Web of Science ®Google Scholar
• Norden AGWV, Fick WF, De Laat KF, et al. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions. Neurology. 2008;71(15):1152–1159. doi: 10.1212/01.wnl.0000327564.44819.49
   Web of Science ®Google Scholar
• Haley AP, Hoth KF, Gunstad J, et al. Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease. Am J Geriatr Psychiatry. 2009;17(11):976–985. doi: 10.1097/JGP.0b013e3181b208ef
   PubMed Web of Science ®Google Scholar
• Gormley EA, Lightner DJ, Burgio KL, et al. American urological association; society of Urodynamics, female pelvic medicine & urogenital reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6):2455–2463. doi: 10.1016/j.juro.2012.09.079
   PubMed Web of Science ®Google Scholar
• Tedeschini E, Levkovitz Y, Iovieno N, et al. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72(12):1660–1668. doi: 10.4088/JCP.10r06531
   PubMed Web of Science ®Google Scholar
• Reppas-Rindlisbacher CE, Fischer HD, Fung K, et al. Anticholinergic drug burden in persons with dementia taking a cholinesterase inhibitor: the effect of multiple physicians. J Am Geriatr Soc. 2016;64(3):492–500. doi: 10.1111/jgs.14034
   Web of Science ®Google Scholar
• vans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262(18):2551–2556. doi: 10.1001/jama.1989.03430180093036
   Web of Science ®Google Scholar
• Ott A, Breteler MM, van Harskamp F, et al. Incidence and risk of dementia. The Rotterdam study. Am J Epidemiol. 1998;147(6):574–580. doi: 10.1093/oxfordjournals.aje.a009489
   PubMed Web of Science ®Google Scholar
• Morimoto SS, Kanellopoulos D, Manning KJ, et al. Diagnosis and treatment of depression and cognitive impairment in late life. Ann N Y Acad Sci. 2015;1345:36–46. doi: 10.1111/nyas.12669
   PubMed Web of Science ®Google Scholar
• Gonda X, Pompili M, Serafini G, et al. The role of cognitive dysfunction in the symptoms and remission from depression. Ann Gen Psychiatry. 2015;14:32. doi: 10.1186/s12991-015-0068-9
   Web of Science ®Google Scholar
• Covington LP, McCarrell J, Hoerster NS. Prevalence of anticholinergic medication use in the program of all-inclusive care for the elderly. Consult Pharm. 2016;31(3):168–174. doi: 10.4140/TCP.n.2016.168
   Google Scholar